Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-23 Sale |
2023-01-23 5:35 pm |
Evelo Biosciences Inc. | EVLO | CARRIERE STEPHEN J Principal Accounting Officer |
151 | $1.0604 | $160 | 1,266 (Direct) |
View |
| 2022-05-27 Purchase |
2022-06-01 7:00 pm |
Evelo Biosciences Inc. | EVLO | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund IV-Rx L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. Nutritional Health LTP Fund General Partner LLC Nutritional Health LTP Fund L.P. Flagship Pioneering Inc. AFEYAN NOUBAR 10% Owner |
27,397,259 | $1.46 | $39,999,998 | 27,233,921 (Indirect) |
View |
| 2022-05-27 Purchase |
2022-05-31 4:15 pm |
Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer |
34,246 | $1.46 | $49,999 | 34,246 (Direct) |
View |
| 2022-05-27 Purchase |
2022-05-31 4:11 pm |
Evelo Biosciences Inc. | EVLO | Darzi Lord Ara Director |
342,465 | $1.46 | $499,999 | 342,465 (Direct) |
View |
| 2022-05-27 Purchase |
2022-05-31 4:07 pm |
Evelo Biosciences Inc. | EVLO | Epstein David R Director |
17,123 | $1.46 | $25,000 | 84,080 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-04-14 Option Award |
2023-04-18 5:12 pm |
N/A 2033-04-14 |
Evelo Biosciences Inc. | EVLO | Rosiello Robert L. Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-09 4:38 pm |
N/A 2033-02-07 |
Evelo Biosciences Inc. | EVLO | GILL SIMBA President & CEO |
1,500,000 | $0 | 1,500,000 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-09 4:32 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D |
530,000 | $0 | 530,000 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-09 4:28 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer |
520,000 | $0 | 520,000 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-09 4:25 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer |
520,000 | $0 | 520,000 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 4:10 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Plinio Mark D. Chief Commercial Officer |
1,250 | $0.88 | 3,750 (Direct) |
View |
| 2023-01-19 Exercise |
2023-01-23 5:35 pm |
N/A 2032-01-19 |
Evelo Biosciences Inc. | EVLO | CARRIERE STEPHEN J Principal Accounting Officer |
354 | $0 | 1,266 (Direct) |
View |
| 2022-07-19 Option Award |
2022-10-14 4:37 pm |
N/A 2032-07-19 |
Evelo Biosciences Inc. | EVLO | Char Daniel General Counsel |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-07-19 Option Award |
2022-10-14 4:32 pm |
N/A 2032-07-19 |
Evelo Biosciences Inc. | EVLO | Zung Jonathan B. Chief Development Officer |
115,000 | $0 | 115,000 (Direct) |
View |
| 2022-07-29 Option Award |
2022-10-14 4:24 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Plinio Mark D. Chief Commercial Officer |
1,250 | $1.79 | 2,500 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-01 4:52 pm |
N/A 2032-09-01 |
Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer |
440,000 | $0 | 440,000 (Direct) |
View |
| 2022-06-30 Exercise |
2022-06-30 4:52 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Epstein David R Director |
4,927 | $0 | 93,932 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:53 pm |
N/A 2032-06-09 |
Evelo Biosciences Inc. | EVLO | MELAS KYRIAZI THEO Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:50 pm |
N/A 2032-06-09 |
Evelo Biosciences Inc. | EVLO | McInnes Iain B. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:48 pm |
N/A 2032-06-09 |
Evelo Biosciences Inc. | EVLO | McHugh Julie Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:44 pm |
N/A 2032-06-09 |
Evelo Biosciences Inc. | EVLO | Hohneker John Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 4:41 pm |
N/A 2032-06-10 |
Evelo Biosciences Inc. | EVLO | Epstein David R Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:38 pm |
N/A 2032-06-09 |
Evelo Biosciences Inc. | EVLO | Darzi Lord Ara Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:35 pm |
N/A 2032-06-09 |
Evelo Biosciences Inc. | EVLO | Andres Juan Director |
20,000 | $0 | 20,000 (Direct) |
View |
Ownership |
2022-06-01 7:00 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Flagship Pioneering Fund VII General Partner LLC Flagship Pioneering Fund VII L.P. 10% Owner |
0 | $0 | 13,698,630 (Indirect) |
View |
| 2022-05-31 Exercise |
2022-06-01 4:12 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Epstein David R Director |
4,925 | $0 | 93,932 (Direct) |
View |
| 2022-05-02 Exercise |
2022-05-02 4:03 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Epstein David R Director |
4,926 | $0 | 76,809 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 5:41 pm |
N/A 2032-04-01 |
Evelo Biosciences Inc. | EVLO | Gutierrez-Ramos Jose-Carlos Director |
40,000 | $0 | 40,000 (Direct) |
View |
Ownership |
2022-04-05 5:36 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Gutierrez-Ramos Jose-Carlos Director |
0 | $0 | 10,000 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 5:32 pm |
N/A 2032-04-01 |
Evelo Biosciences Inc. | EVLO | Williams Tonya Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-01 4:05 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Epstein David R Director |
4,926 | $0 | 76,809 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-01 4:07 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Epstein David R Director |
4,926 | $0 | 76,809 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-01 5:31 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Plinio Mark D. Chief Commercial Officer |
1,250 | $4.0035 | 1,250 (Direct) |
View |
| 2022-01-31 Exercise |
2022-01-31 5:06 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Epstein David R Director |
4,925 | $0 | 76,809 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 5:02 pm |
N/A 2032-01-19 |
Evelo Biosciences Inc. | EVLO | CARRIERE STEPHEN J Principal Accounting Officer |
7,667 | $0 | 7,667 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 5:00 pm |
N/A 2032-01-19 |
Evelo Biosciences Inc. | EVLO | Char Daniel General Counsel |
80,000 | $0 | 80,000 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:58 pm |
N/A 2032-01-19 |
Evelo Biosciences Inc. | EVLO | Plinio Mark D. Chief Commercial Officer |
60,000 | $0 | 60,000 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:56 pm |
N/A 2032-01-19 |
Evelo Biosciences Inc. | EVLO | Zung Jonathan B. Chief Development Officer |
115,000 | $0 | 115,000 (Direct) |
View |